Device
nasal intermittent positive pressure ventilation
nasal intermittent positive pressure ventilation is a medical device with 3 clinical trials. Historical success rate of 33.3%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
2(67%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Terminated2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed133%
terminated267%
Recent Activity
0 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT03670732Not Applicable
CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure
NCT03137225Not Applicable
Noninvasive NAVA Versus NIPPV in Low Birthweight Premature Infants
NCT00821119Not Applicable
Trial of Non Invasive Ventilation for Respiratoy Distress Syndrome
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3